Besides, network MR analysis in the present study partially sheds light on the biological network from GP73 to CAD thus, targeted interventions acting on the identified mediators along the causal pathway, e.g., management of dyslipidemia and hyperglycemia, are also helpful to minimize the harmful effects of GP73 on CAD. This evidence concerns the gene GOLM1 and coronary artery disorder.